Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
180.35
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Mar 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,354
Open
180.35
Bid (Size)
180.45 (1)
Ask (Size)
181.00 (2)
Prev. Close
180.35
Today's Range
180.35 - 180.35
52wk Range
130.96 - 182.89
Shares Outstanding
N/A
Dividend Yield
3.28%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
Today 8:00 EDT
The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting.
Via
Investor's Business Daily
Exposures
Product Safety
Long Live the Dividend Kings: 3 Top Picks to Build an Income Portfolio
Today 6:00 EDT
The dividend kings are excellent stocks with which to establish an income portfolio with these three dividend king stocks standing out.
Via
InvestorPlace
Performance
YTD
+12.85%
+12.85%
1 Month
+0.86%
+0.86%
3 Month
+16.44%
+16.44%
6 Month
+17.78%
+17.78%
1 Year
+13.97%
+13.97%
More News
Read More
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
March 27, 2024
Via
Benzinga
Assessing AbbVie's Performance Against Competitors In Biotechnology Industry
March 26, 2024
Via
Benzinga
Tuesday Talk: Big-Tech Under Attack
March 26, 2024
Via
Talk Markets
The Latest Analyst Ratings For AbbVie
March 22, 2024
Via
Benzinga
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today
March 18, 2024
Via
Benzinga
Decoding AbbVie's Options Activity: What's the Big Picture?
March 14, 2024
Via
Benzinga
Biotechnology And Healthcare, A Bit Of A Lull
March 25, 2024
Via
Talk Markets
Nasdaq Turns Higher; Akanda Shares Plunge
March 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Via
Benzinga
Why Is Landos Biopharma (LABP) Stock Up 168% Today?
March 25, 2024
Via
InvestorPlace
Crude Oil Moves Higher; US New Home Sales Fall In February
March 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday?
March 25, 2024
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Kinnate Biopharma Inc. (Nasdaq – KNTE)
March 25, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
US Stocks Down; Chicago Fed National Activity Index Rises In February
March 25, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
March 24, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
GlycoMimetics: A Potential Game Changer In Blood Cancers With Near-Term Catalysts
March 21, 2024
Via
Talk Markets
Healthcare And Biotech Update With Market At 2024 Highs
March 20, 2024
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
March 19, 2024
Via
Benzinga
The Next Great Biotech Boom Has Arrived
March 19, 2024
Via
FinancialNewsMedia
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2024
Via
Benzinga
2 Top Dividend Stocks to Buy Hand Over Fist
March 17, 2024
Via
The Motley Fool
How Much a $1 Million Portfolio Would Pay in Dividends
March 13, 2024
Via
The Motley Fool
SCHD ETF Spotlight: The Top 6 Stocks Inside This Dividend Monster
March 13, 2024
Via
InvestorPlace
Topics
ETFs
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.